European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationale

Jake P Mann, Anita Vreugdenhil, Piotr Socha, Wojciech Jańczyk, Ulrich Baumann, Sanjay Rajwal, Thomas Casswall, Claude Marcus, Indra van Mourik, Stephen O'Rahilly, David B Savage, Gabriele Noble-Jamieson, Florence Lacaille, Myriam Dabbas, Béatrice Dubern, Deirdre A Kelly, Valerio Nobili, Quentin M Anstee

Research output: Contribution to journalArticlepeer-review

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in children and has the potential to progress to advanced fibrosis/cirrhosis, end-stage liver disease and hepatocellular carcinoma. However, the natural history of the condition is poorly understood and there are no approved treatments. The European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD) is a multi-centre registry of paediatric NAFLD that will serve as a prospective, observational, natural history study and provide a tractable back-bone to support recruitment into subsequent interventional trials. Collection of samples into a bio-repository will facilitate translational studies, including genome sequencing and metabolomics. EU-PNAFLD will work closely alongside the existing adult European NAFLD Registry to obtain data on clinical outcomes after 20-30 years. Through an international, well-characterised large-scale cohort, EU-PNAFLD will address the key questions in paediatric NAFLD and benefit patients with the condition.

Original languageEnglish
Pages (from-to)67-71
Number of pages5
JournalContemporary Clinical Trials
Volume75
DOIs
Publication statusPublished - Dec 2018

Fingerprint Dive into the research topics of 'European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationale'. Together they form a unique fingerprint.

Cite this